Park Hyojin, Lee Sungwoon, Shrestha Pravesh, Kim Jihye, Park Jeong Ae, Ko Yeongrim, Ban Young Ho, Park Dae-Young, Ha Sang-Jun, Koh Gou Young, Hong Victor Sukbong, Mochizuki Naoki, Kim Young-Myeong, Lee Weontae, Kwon Young-Guen
Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
J Cell Biol. 2015 Nov 9;211(3):619-37. doi: 10.1083/jcb.201503113.
The phosphoinositide 3-kinase-Akt signaling pathway is essential to many biological processes, including cell proliferation, survival, metabolism, and angiogenesis, under pathophysiological conditions. Although 3-phosphoinositide-dependent kinase 1 (PDK1) is a primary activator of Akt at the plasma membrane, the optimal activation mechanism remains unclear. We report that adhesion molecule with IgG-like domain 2 (AMIGO2) is a novel scaffold protein that regulates PDK1 membrane localization and Akt activation. Loss of AMIGO2 in endothelial cells (ECs) led to apoptosis and inhibition of angiogenesis with Akt inactivation. Amino acid residues 465-474 in AMIGO2 directly bind to the PDK1 pleckstrin homology domain. A synthetic peptide containing the AMIGO2 465-474 residues abrogated the AMIGO2-PDK1 interaction and Akt activation. Moreover, it effectively suppressed pathological angiogenesis in murine tumor and oxygen-induced retinopathy models. These results demonstrate that AMIGO2 is an important regulator of the PDK1-Akt pathway in ECs and suggest that interference of the PDK1-AMIGO2 interaction might be a novel pharmaceutical target for designing an Akt pathway inhibitor.
在病理生理条件下,磷酸肌醇3激酶-蛋白激酶B(Akt)信号通路对包括细胞增殖、存活、代谢和血管生成在内的许多生物学过程至关重要。虽然3-磷酸肌醇依赖性激酶1(PDK1)是Akt在质膜上的主要激活剂,但其最佳激活机制仍不清楚。我们报告,具有IgG样结构域2的黏附分子(AMIGO2)是一种新型支架蛋白,可调节PDK1的膜定位和Akt激活。内皮细胞(ECs)中AMIGO2的缺失导致细胞凋亡和血管生成抑制,并伴有Akt失活。AMIGO2中的465-474位氨基酸残基直接与PDK1的普列克底物蛋白同源结构域结合。一种含有AMIGO2 465-474位残基的合成肽消除了AMIGO2与PDK1的相互作用以及Akt激活。此外,它有效抑制了小鼠肿瘤和氧诱导性视网膜病变模型中的病理性血管生成。这些结果表明,AMIGO2是ECs中PDK1-Akt通路的重要调节因子,并提示干扰PDK1与AMIGO2的相互作用可能是设计Akt通路抑制剂的新型药物靶点。